You have no items in your shopping cart.
Search results for: 'active'
RecombinantMCP-1/CCL2,Rat [orb1494632]> 98% as analyzed by SDS-PAGE.
10~15 kDa, observed by reducing SDS-PAGE.
HEK 293
25 μg, 5 μg- RecombinantMCP-1/CCL2,Mouse [orb1494633]
> 98% as analyzed by SDS-PAGE.
8 kDa, observed by reducing SDS-PAGE.
HEK 293
25 μg, 5 μg, 1 mg - RecombinantI‑TAC/CXCL11,Human(HEK293-expressed) [orb1494634]
> 98% as analyzed by SDS-PAGE.
8.3 kDa, observed by reducing SDS-PAGE.
HEK 293
50 μg, 10 μg - RecombinantIP-10/CRG-2/CXCL10,Rat [orb1494635]
> 98% as analyzed by SDS-PAGE.
8.7 kDa, observed by reducing SDS-PAGE.
HEK 293
25 μg, 5 μg, 1 mg - RecombinantIL-2Rα,His,Human [orb1494639]
> 95% as analyzed by SDS-PAGE and HPLC.
42 kDa, observed by reducing SDS-PAGE.
HEK 293
50 μg, 10 μg, 1 mg - RecombinantFractalkine/CX3CL1,Rat [orb1494649]
> 98% as analyzed by SDS-PAGE.
70-90 kDa, observed by reducing SDS-PAGE.
HEK 293
50 μg, 10 μg, 1 mg - RecombinantFasR,Human [orb1494650]
> 95% as analyzed by SDS-PAGE.
17~29 kDa, observed by reducing SDS-PAGE.
HEK 293
10 μg, 50 μg, 1 mg - RecombinantCT‑1,Mouse [orb1494652]
> 95% as analyzed by SDS-PAGE.
22~27 kDa, observed by reducing SDS-PAGE.
HEK 293
50 μg, 10 μg, 1 mg - RecombinantVEGF-D,Human [orb1494659]
> 95% as analyzed by SDS-PAGE and HPLC.
18-19 kDa, observed by reducing SDS-PAGE.
CHO
50 μg, 10 μg, 1 mg - RecombinantTPO,His,Rat [orb1494663]
> 98% as analyzed by SDS-PAGE.
22 kDa, observed by reducing SDS-PAGE.
CHO
50 μg, 10 μg